The United States Pharmacopeial Convention (USP), a non-profit, standards setting organisation that advances public health through public standards, has named Kiran Mazumdar-Shaw, CMD of Biocon, on its board of trustees.
Shaw, the second non-US member to join the board of trustees, will help guide USP’s policies, finances and strategic direction. In addition, she will serve as a member of the USP Biologics Advisory Group.
USP develops standards for the identity, purity, quality and strength of medicines, medicinal ingredients, botanical medicinal ingredients, dietary supplements, food ingredients and compounded medicines manufactured, prepared, distributed and consumed worldwide.
Headquartered in the US, it operates facilities with laboratories and customer support operations in Brazil, India and China, with a sales office in Switzerland.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.